Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Rutter

Showing results (1-10 of 265) with videos related to

Pageof 27
Sort By:
Diabetologia|December 4, 2015
Night-time blood pressure: a role in the prediction and prevention of diabetes?Martin K Rutter
Diabetologia|September 16, 2017
Devoting attention to glucose variability and hypoglycaemia in type 2 diabetesMartin K Rutter
Diabetologia|July 19, 2012
Low HbA1c and mortality: causation and confoundingM K Rutter
Alimentary Pharmacology & Therapeutics|August 14, 2013
Commentary: durability of SVR in chronic hepatitis C patients treated with peginterferon-a2a/ribavirin in combination with a direct-acting anti-viral--authors' replyP Ferenci, K Rutter
British Medical Journal|October 23, 1976
Diseases of the alimentary system. Constipation and laxative abuseK Rutter, D Maxwell
The Lancet. Diabetes & Endocrinology|February 4, 2018
Personalised blood pressure ranges in type 2 diabetes?Martin K Rutter, Naveed Sattar
Plos Medicine|April 24, 2025
The cardiology community begins to embrace obesity as an important target for cardiovascular healthNaveed Sattar, Martin K Rutter
Acta Diabetologica|September 12, 2002
Impact of the atherosclerotic process in patients with diabetesR W Nesto, M K Rutter
European Heart Journal|June 28, 2011
Blood pressure, lipids and glucose in type 2 diabetes: how low should we go? Re-discovering personalized careMartin K Rutter, Richard W Nesto
Diabetes & Vascular Disease Research|April 7, 2010
The BARI 2D study: a randomised trial of therapies for type 2 diabetes and coronary artery diseaseMartin K Rutter, Richard W Nesto
Pageof 27

Showing results (1-10 of 265) with videos related to

Sort By:
Pageof 27
Diabetologia|December 4, 2015
Night-time blood pressure: a role in the prediction and prevention of diabetes?Martin K Rutter
Diabetologia|September 16, 2017
Devoting attention to glucose variability and hypoglycaemia in type 2 diabetesMartin K Rutter
Diabetologia|July 19, 2012
Low HbA1c and mortality: causation and confoundingM K Rutter
Alimentary Pharmacology & Therapeutics|August 14, 2013
Commentary: durability of SVR in chronic hepatitis C patients treated with peginterferon-a2a/ribavirin in combination with a direct-acting anti-viral--authors' replyP Ferenci, K Rutter
British Medical Journal|October 23, 1976
Diseases of the alimentary system. Constipation and laxative abuseK Rutter, D Maxwell
The Lancet. Diabetes & Endocrinology|February 4, 2018
Personalised blood pressure ranges in type 2 diabetes?Martin K Rutter, Naveed Sattar
Plos Medicine|April 24, 2025
The cardiology community begins to embrace obesity as an important target for cardiovascular healthNaveed Sattar, Martin K Rutter
Acta Diabetologica|September 12, 2002
Impact of the atherosclerotic process in patients with diabetesR W Nesto, M K Rutter
European Heart Journal|June 28, 2011
Blood pressure, lipids and glucose in type 2 diabetes: how low should we go? Re-discovering personalized careMartin K Rutter, Richard W Nesto
Diabetes & Vascular Disease Research|April 7, 2010
The BARI 2D study: a randomised trial of therapies for type 2 diabetes and coronary artery diseaseMartin K Rutter, Richard W Nesto
Pageof 27